Simplicity Wealth’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
Other funds holding TERN
O
VC
SCM
DTC
VA
SSA
Simplicity Wealth's TERN Position: Q3 2024 in Review
Simplicity Wealth sold out of Terns Pharmaceuticals (TERN) in Q3 2024, closing a stake of 10,561 shares — an estimated $71.9K sold.
Simplicity Wealth first reported a position in TERN in Q2 2024 and held it in 1 quarter. The position peaked at $71.9K in Q2 2024. 156 funds tracked by Wall St. Rank hold TERN as of Q3 2024.
- Simplicity Wealth reported no remaining Terns Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
- Simplicity Wealth sold 10,561 Terns Pharmaceuticals shares in Q3 2024, an estimated $71.9K.
- Simplicity Wealth first reported a position in Terns Pharmaceuticals in Q2 2024 and held it in 1 quarter.
- Simplicity Wealth's Terns Pharmaceuticals position peaked at $71.9K in Q2 2024.
- 156 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q3 2024.
Based on Simplicity Wealth's 13F filing for Q3 2024, filed 10 Oct 2024.